Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$890.68 USD
-15.86 (-1.75%)
Updated Apr 25, 2024 04:00 PM ET
Pre-Market: $890.44 -0.24 (-0.03%) 8:58 AM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: BMO |
3/2024 | $10.09 | -0.79% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $11.86 per share, beating the Zacks Consensus Estimate of $10.43 per share. This reflects a positive earnings surprise of 13.71%. Look out for REGN's next earnings release on May 02, 2024. For the next earning release, we expect the company to report earnings of $10.09 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for REGN
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services